Search Results - "Johannsen, Eric C."

Refine Results
  1. 1

    An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle by Chakravorty, Adityarup, Sugden, Bill, Johannsen, Eric C

    Published in Journal of virology (15-04-2019)
    “…The Epstein-Barr virus (EBV) lytic phase, like those of all herpesviruses, proceeds via an orderly cascade that integrates DNA replication and gene expression…”
    Get full text
    Journal Article
  2. 2

    Epstein-Barr Virus Oncoprotein Super-enhancers Control B Cell Growth by Zhou, Hufeng, Schmidt, Stefanie C.S., Jiang, Sizun, Willox, Bradford, Bernhardt, Katharina, Liang, Jun, Johannsen, Eric C., Kharchenko, Peter, Gewurz, Benjamin E., Kieff, Elliott, Zhao, Bo

    Published in Cell host & microbe (11-02-2015)
    “…Super-enhancers are clusters of gene-regulatory sites bound by multiple transcription factors that govern cell transcription, development, phenotype, and…”
    Get full text
    Journal Article
  3. 3

    A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection by Bristol, Jillian A, Djavadian, Reza, Albright, Emily R, Coleman, Carrie B, Ohashi, Makoto, Hayes, Mitchell, Romero-Masters, James C, Barlow, Elizabeth A, Farrell, Paul J, Rochford, Rosemary, Kalejta, Robert F, Johannsen, Eric C, Kenney, Shannon C

    Published in PLoS pathogens (27-07-2018)
    “…Latent Epstein-Barr virus (EBV) infection contributes to both B-cell and epithelial-cell malignancies. However, whether lytic EBV infection also contributes to…”
    Get full text
    Journal Article
  4. 4

    Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells by Van Sciver, Nicholas, Ohashi, Makoto, Pauly, Nicholas P, Bristol, Jillian A, Nelson, Scott E, Johannsen, Eric C, Kenney, Shannon C

    Published in PLoS pathogens (02-08-2021)
    “…The Epstein-Barr virus (EBV) human herpesvirus is associated with B-cell and epithelial-cell malignancies, and both the latent and lytic forms of viral…”
    Get full text
    Journal Article
  5. 5

    Epstein—Barr Virus Nuclear Antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A by Jiang, Sizun, Willox, Bradford, Zhou, Hufeng, Holthaus, Amy M., Wang, Anqi, Shi, Tommy T., Maruo, Seiji, Kharchenko, Peter V., Johannsen, Eric C., Kieff, Elliott, Zhao, Bo

    “…Epstein—Barr virus nuclear antigen 3C (EBNA3C) repression of CDKN2A p14ARF and p16INK4A is essential for immortal human B-lymphoblastoid cell line (LCL)…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency by Wille, Coral K, Li, Yangguang, Rui, Lixin, Johannsen, Eric C, Kenney, Shannon C

    Published in Journal of virology (01-03-2017)
    “…Epstein-Barr virus (EBV) latently infects normal B cells and contributes to the development of certain human lymphomas. Newly infected B cells support a highly…”
    Get full text
    Journal Article
  8. 8

    Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice by Bristol, Jillian A, Nelson, Scott E, Ohashi, Makoto, Casco, Alejandro, Hayes, Mitchell, Ranheim, Erik A, Pawelski, Abigail S, Singh, Deo R, Hodson, Daniel J, Johannsen, Eric C, Kenney, Shannon C

    Published in PLoS pathogens (01-04-2024)
    “…Epstein-Barr virus (EBV) is an important cause of human lymphomas, including Burkitt lymphoma (BL). EBV+ BLs are driven by Myc translocation and have stringent…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells by Bristol, Jillian A, Brand, Joshua, Ohashi, Makoto, Eichelberg, Mark R, Casco, Alejandro, Nelson, Scott E, Hayes, Mitchell, Romero-Masters, James C, Baiu, Dana C, Gumperz, Jenny E, Johannsen, Eric C, Dinh, Huy Q, Kenney, Shannon C

    Published in PLoS pathogens (01-04-2022)
    “…Humans are infected with two types of EBV (Type 1 (T1) and Type 2 (T2)) that differ substantially in their EBNA2 and EBNA 3A/B/C latency proteins and have…”
    Get full text
    Journal Article
  12. 12

    ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells by Van Sciver, Nicholas, Ohashi, Makoto, Nawandar, Dhananjay M, Pauly, Nicholas P, Lee, Denis, Makielski, Kathleen R, Bristol, Jillian A, Tsao, Sai Wah, Lambert, Paul F, Johannsen, Eric C, Kenney, Shannon C

    Published in PLoS pathogens (01-11-2021)
    “…Epstein-Barr virus (EBV) is a human herpesvirus that causes infectious mononucleosis and contributes to both B-cell and epithelial-cell malignancies…”
    Get full text
    Journal Article
  13. 13

    Epstein–Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes by Schmidt, Stefanie C. S., Jiang, Sizun, Zhou, Hufeng, Willox, Bradford, Holthaus, Amy M., Kharchenko, Peter V., Johannsen, Eric C., Kieff, Elliott, Zhao, Bo

    “…Significance Epstein–Barr Virus (EBV)-infected lymphoblasts can give rise to non-Hodgkin’s lymphomas, Hodgkin’s disease, and lymphoproliferative disorders,…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    5-hydroxymethylation of the EBV genome regulates the latent to lytic switch by Wille, Coral K., Nawandar, Dhananjay M., Henning, Amanda N., Ma, Shidong, Oetting, Kayla M., Lee, Dennis, Lambert, Paul, Johannsen, Eric C., Kenney, Shannon C.

    “…Latent Epstein–Barr virus (EBV) infection and cellular hypermethylation are hallmarks of undifferentiated nasopharyngeal carcinoma (NPC). However, EBV…”
    Get full text
    Journal Article
  17. 17

    Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection by Price, Alexander M, Dai, Joanne, Bazot, Quentin, Patel, Luv, Nikitin, Pavel A, Djavadian, Reza, Winter, Peter S, Salinas, Cristina A, Barry, Ashley Perkins, Wood, Kris C, Johannsen, Eric C, Letai, Anthony, Allday, Martin J, Luftig, Micah A

    Published in eLife (20-04-2017)
    “…Latent Epstein-Barr virus (EBV) infection is causally linked to several human cancers. EBV expresses viral oncogenes that promote cell growth and inhibit the…”
    Get full text
    Journal Article
  18. 18

    An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model by Romero-Masters, James C, Ohashi, Makoto, Djavadian, Reza, Eichelberg, Mark R, Hayes, Mitch, Bristol, Jillian A, Ma, Shidong, Ranheim, Erik A, Gumperz, Jenny, Johannsen, Eric C, Kenney, Shannon C

    Published in PLoS pathogens (01-08-2018)
    “…EBV causes human B-cell lymphomas and transforms B cells in vitro. EBNA3C, an EBV protein expressed in latently-infected cells, is required for EBV…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Human CD4+ iNKT cell adoptive immunotherapy induces anti‐tumour responses against CD1d‐negative EBV‐driven B lymphoma by Baiu, Dana C., Sharma, Akshat, Schehr, Jennifer L., Basu, Jayati, Smith, Kelsey A., Ohashi, Makoto, Johannsen, Eric C., Kenney, Shannon C., Gumperz, Jenny E.

    Published in Immunology (01-08-2024)
    “…Invariant natural killer T (iNKT) cells are a conserved population of innate T lymphocytes that are uniquely suitable as off‐the‐shelf cellular immunotherapies…”
    Get full text
    Journal Article